Xponance’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Sell |
|
|||||
|
2025
Q1 | $3.02M | Buy |
|
|||||
|
2024
Q4 | $3.69M | Buy |
|
|||||
|
2024
Q3 | $2.9M | Sell |
|
|||||
|
2024
Q2 | $3.47M | Sell |
|
|||||
|
2024
Q1 | $3.54M | Buy |
|
|||||
|
2023
Q4 | $2.83M | Sell |
|
|||||
|
2023
Q3 | $2.52M | Sell |
|
|||||
|
2023
Q2 | $2.12M | Sell |
|
|||||
|
2023
Q1 | $2.3M | Buy |
|
|||||
|
2022
Q4 | $2.67M | Buy |
|
|||||
|
2022
Q3 | $2.22M | Buy |
|
|||||
|
2022
Q2 | $2.03M | Buy |
|
|||||
|
2022
Q1 | $1.91M | Sell |
|
|||||
|
2021
Q4 | $1.74M | Sell |
|
|||||
|
2021
Q3 | $1.96M | Sell |
|
|||||
|
2021
Q2 | $2.01M | Buy |
|
|||||
|
2021
Q1 | $1.89M | Buy |
|
|||||
|
2020
Q4 | $914K | Sell |
|
|||||
|
2020
Q3 | $926K | Buy |
|
|||||
|
2020
Q2 | $1.16M | Buy |
|